September 13, 2017 – BioIQ, a technology platform driving the employer and health plan shift to value-based care, has been named a finalist for the 2017 TripleTree iAwards. Ten finalists representing healthcare technology and service companies were selected to move to the next round based on their insight, initiative and innovation, and ability to address some of the most pressing needs in healthcare. The award winners will be announced in October and invited to Minneapolis to attend an interactive session with TripleTree professionals, innovators and industry leaders.
“We are excited to be honored as a finalist for the 2017 TripleTree iAwards,” said Justin Bellante, CEO, BioIQ. “This recognition highlights BioIQ’s initiative to provide innovative solutions to payors for quality and value-based care objectives. We strive to adapt to the evolving healthcare industry by using technology and analytics to improve health outcomes, lower costs and better engage patients to take action about their health. We continue to raise awareness and facilitate connections to the healthcare ecosystem. BioIQ is on its way to impact more than 100 million lives.”
BioIQ is a healthcare technology company that enables organizations to connect with their populations, measure vital health metrics, and achieve health improvement goals. BioIQ works with some of the largest employers and health companies in the nation. Since its inception in 2005, BioIQ has launched thousands of successful health improvement programs serving millions of participants.
TripleTree is an independent healthcare merchant bank focused on mergers and acquisitions, growth capital, recapitalizations, strategic advisory and principal investing. Since 1997, the firm has advised and invested in some of the most innovative, high-growth businesses in healthcare. For more, visit www.triple-tree.com.
SVP, Product and Marketing, BioIQ